¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"beta cell of pancreas"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • memory T cell
    ±â¾ïT¼¼Æ÷
  • Merkel cell-neurite complex
    ¸Þ¸£Ä̼¼Æ÷½Å°æµ¹±âº¹ÇÕ, Ã˰¢¼¼Æ÷½Å°æµ¹±âº¹ÇÕü
  • mesangial cell
    Ç÷°ü»çÀ̼¼Æ÷, ¸Þ»êÁö¿ò¼¼Æ÷
  • mesenchymal cell
    Áß°£¿±¼¼Æ÷
  • mesothelial cell
    ÁßÇǼ¼Æ÷
  • microglial cell
    ¹Ì¼¼¾Æ±³¼¼Æ÷, ¼Ò±³¼¼Æ÷
  • natural killer cell leukemia
    ÀÚ¿¬»ìÇØ¼¼Æ÷¹éÇ÷º´
  • nerve cell
    ½Å°æ¼¼Æ÷
  • nerve cell body
    ½Å°æ¼¼Æ÷ü
  • nerve cell process
    ½Å°æ¼¼Æ÷µ¹±â
  • neural crest cell
    ½Å°æ´É¼±¼¼Æ÷
  • neuroendocrine cell
    ½Å°æ³»ºÐºñ¼¼Æ÷
  • neuroepithelial cell
    ½Å°æ»óÇǼ¼Æ÷
  • neuroglial cell
    ½Å°æ¾Æ±³¼¼Æ÷, ½Å°æ±³¼¼Æ÷
  • neurosecretory cell
    ½Å°æºÐºñ¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • round cell
    ¿øÇü¼¼Æ÷
  • satellite cell
    À§¼º¼¼Æ÷
  • scavenger cell
    û¼Ò¼¼Æ÷
  • Schwann¡¯s cell
    ½Å°æÁý¼¼Æ÷
  • sensitized cell
    ¹Î°¨¼¼Æ÷
  • sensory cell
    °¨°¢¼¼Æ÷
  • septal cell
    Á߰ݼ¼Æ÷
  • serous cell
    Àå¾×¼¼Æ÷
  • Sertoli cell
    (¢¡supporting cell) ¹öÆÀ¼¼Æ÷
  • sexual cell
    (¢¡germ cell) Á¾ÀÚ¼¼Æ÷, ¹è¾Æ¼¼Æ÷, »ý½Ä¼¼Æ÷
  • sickle cell
    ³´ÀûÇ÷±¸
  • signet ring cell carcinoma
    ¹ÝÁö¼¼Æ÷¾ÏÁ¾
  • signet-ring cell
    ¹ÝÁö¼¼Æ÷
  • slide cell culture
    ½½¶óÀ̵弼Æ÷¹è¾ç
  • small cell carcinoma
    ¼Ò¼¼Æ÷¾ÏÁ¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷(Ò®êáÙ¾á¬øà).
  • inner hair cell
    ¼ÓÅм¼Æ÷
  • inner hair cell
    ³»À¯¸ð¼¼Æ÷
  • inner phalangeal cell
    ¼Ó¼Õ°¡¶ô¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷(¡­á¬øà).
  • inner pillar cell
    ¼Ó±âµÕ¼¼Æ÷
  • inner pillar cell
    ³»ÁÖ¼¼Æ÷
  • inner sustentacular cell
    ¼Ó¹öÆÀ¼¼Æ÷
  • insulin secreting islet cell tumor
    Àν¶¸° ºÐºñ¼º µµ¼¼Æ÷Á¾¾ç.
  • interaction, T-B cell
    T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
  • interaction, T-T cell
    T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
  • persensitized cell
    °ú°¨ÀÛ¼¼Æ÷(ΦÊïíÂá¬øà)
  • petrous tip cell
    Ãßü÷ºÀ¼Ò.
  • photochemical cell
    ±¤È­ÇÐÀüÁö(ÎÃûùùÊ ï³ò®).
  • photoconductive cell
    ±¤Àüµµ¼ÒÀÚ(¡­áÈí­).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • cell mass
    ¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
  • cell mass
    ¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
  • cell matrix
    ¼¼Æ÷±âÁú
  • cell maturation
    ¼¼Æ÷¼º¼÷
  • cell mediated hypersensitivity
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • cell mediated immunity
    ¼¼Æ÷¼º¸é¿ª.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷(¸Å°³)¸é¿ª°áÇÌÁõÈıº.
  • cell mediated immunity deficiency syndrome
    ¼¼Æ÷¼º¸é¿ª°áÇÌÁõÈıº.
  • cell mediated lympholysis
    ¼¼Æ÷¸Å°³ ¸²ÇÁ±¸¿ëÇØ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ
  • cell mediated reaction
    ¼¼Æ÷¸Å°³¼º ¹ÝÀÀ.
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane
    ¼¼Æ÷¸·(á¬øàØ¯)
  • cell membrane
    ¼¼Æ÷¸·
  • cell membrane permeability
    ¼¼Æ÷¸·Åõ°ú¼º(á¬øàØ¯÷âΦàõ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
LCRB locus control region beta
LHB luteinizing hormone beta chain
MANB mannosidase beta
MBAR myocardial beta adrenergic receptor
MIBT methyl isatin-beta-thiosemicarbazone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
IL-2R beta IL-2 receptor beta
IR-beta EP Immunoreactive beta-endorphin
IFN alpha/beta Interferon alpha/beta
IFN-beta Interferon beta
IL-1 beta interlukin-1 beta
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • plasma cell dyscrasia
    Ç÷Àå ¼¼Æ÷ ÀÌ»ó
  • plasma cell pneumonia
    ÇüÁú ¼¼Æ÷¼º Æó·Å
  • pleomorphic cell
    ´ÙÇü ¼¼Æ÷
  • pluripotential stem cell
    ´Ù´É¼º °£ ¼¼Æ÷
  • PNH cell
    PNH ¼¼Æ÷
    ¹ßÀÛ¼º ¾ß°£ Ç÷»ö´¢Áõ¿¡¼­ º¸ÀÌ´Â ÀûÇ÷±¸. ÀÌµé ¼¼Æ÷´Â Á¤»ó ¶Ç´Â Á¤»ó À¯»ç ¼¼Æ÷
  • polyhedral cell
    ¹µ¸éü ¼¼Æ÷
  • postmitotic maturing cell
    °¨¼öºÐ¿­ ÈÄ ¼º¼÷ ¼¼Æ÷
  • prickel cell
    ±Ø ¼¼Æ÷
  • prickle cell carcinoma
    ±Ø¼¼Æ÷ ¾Ï
  • prickle cell layer
    ±Ø¼¼Æ÷ Ãþ, À¯±Ø ¼¼Æ÷Ãþ, °¡½ÃÃþ, À¯±ØÃþ
    ÀÎÁ¢ ¼¼Æ÷¿Í ¼¼Æ÷°£±³¸¦ Çü¼ºÇϰí ÀÖ´Â °¢È­ ±¸°­ »óÇÇÀÇ ÇÑ ¼¼Æ÷Ãþ.
  • primary afferent cell body
    ÀÏÂ÷ ±¸½É¼º ¼¼Æ÷ü
  • primitive myoid cell
    ¿ø½Ã ±Ù ¼Ò¼¼Æ÷
  • primordial germ cell
    ¿ø½Ã »ý½Ä¼¼Æ÷, ½Ã¿ø »ý½Ä ¼¼Æ÷
    »ý¹°ÀÇ ¹ß»ý Ãʱ⿡ ÀåÂ÷ »ý½Ä¼Ò·Î ºÐÈ­µÉ ¿¹Á¤ÀÎ ¼¼Æ÷¿ª¿¡ À־ÀÇ ¹ÌºÐÈ­ »ý½Ä ¼¼Æ÷. ¿ø½Ã »ý½Ä ¼¼Æ÷, ½Ã¿ø¼º ¼¼Æ÷¶ó°íµµ ÇÑ´Ù. ¹ß»ýÀÌ ÁøÇàµÇ¸é »ý½Ä¼ÒÀÇ ³­¿ø ¼¼Æ÷ ¶Ç´Â Á¤¿ø ¼¼Æ÷·Î ºÐÈ­ÇÑ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ´Ù¸¥ Á¶Á÷ ¼¼Æ÷¿Í ±¸º°µÇ´Â ÇüÅÂÀû Ư¡À» °¡Áö¸ç, ¶ÇÇÑ »ý½Ä¼ÒÀÇ ¿¹Á¤¿ªº¸´Ù »ó´çÈ÷ ¶³¾îÁø ¹è¿ª¿¡ Á¸ÀçÇÑ´Ù. ÀÌ ¹è¿ª¿¡ Àå¾Ö¸¦ ÁÖ¸é »ý½Ä ¼¼Æ÷ÀÇ ºÐÈ­°¡ ÀϾÁö ¾Ê°Ô µÈ´Ù. ½Ã¿ø »ý½Ä ¼¼Æ÷´Â ü¼¼Æ÷¿Í´Â ¸í¹éÇÏ°Ô ±¸º°µÇ¸ç, ü¼¼Æ÷·ÎºÎÅÍ ½Ã¿ø »ý½Ä ¼¼Æ÷·Î ºÐÈ­µÇÁö ¾Ê´Â´Ù°í ÇÏ´Â »ý½ÄÁú ¿¬¼Ó¼³ÀÌ ÀϹÝÀûÀ¸·Î ÀÎÁ¤µÇ°í ÀÖ´Ù. ¿¹¸¦ µé¸é, ¸»È¸ÃæÀº 2°³ÀÇ ¿°»öü¸¦ °¡Áö´Âµ¥, À̰ÍÀº ÃÖÃÊÀÇ ³­ºÐÇÒ ¶§ºÎÅÍ »ý½Ä ¼¼Æ÷°è¿Í ü¼¼Æ÷°è·Î ³ª´©¾îÁø´Ù. »ý½Ä ¼¼Æ÷°è´Â 2°³ÀÇ ¿°»öü¸¦ °¡Áö°í ¿¬¼ÓÇÏÁö¸¸, ü¼¼Æ÷°è´Â ¿°»öü¿¡ Àý´ÜÀÌ ÀϾ¼­ ´Ù¼öÀÇ ¿°»öü ¼ö¸¦ °¡Áö´Â ¼¼Æ÷°è·Î ºÐÈ­ÇÑ´Ù.
  • principal cell
    ÁÖ ¼¼Æ÷
  • projection cell
    Åõ»ç ¼¼Æ÷
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
1-beta-d-ribofuranosylcytosine <biochemistry> Nucleoside consisting of D ribose and the pyrimidine base cytosine.
(18 Nov 1997)
1-beta-d-ribofuranosyluracil <biochemistry> The ribonucleoside formed by the combination of ribose and uracil.
(18 Nov 1997)
lactatriaosylceramide beta 1-3 galactosyltransferase <enzyme> Glycolipid beta 1-3 galactosyltransferase
Registry number: EC 2.4.1.-
Synonym: ltc 1-3 galactosyltransferase
(26 Jun 1999)
2-O-alpha-D-glucopyranosyl-O-beta-D-galactopyranosyl-hydroxylysine glucohydrolase <enzyme> Responsible for catabolism of hydroxylysine-linked disaccharide unit derived from collagen in mammals
Registry number: EC 3.2.1.-
Synonym: glc-gal-hyl glucohydrolase, ggh-glucohydrolase
(26 Jun 1999)
3 alpha-hydroxysteroid-5 beta-oxidoreductase <enzyme> From digitalis lanata; specific for 5 beta-pregnan-3-ones; does not act on 5 alpha-pregnane-3-ones or delta 4/delta 5-pregnenes
Registry number: EC 1.1.1-
Synonym: 3a ohs oxidoreductase
(26 Jun 1999)
3 beta,20 alpha-hydroxysteroid oxidoreductase <enzyme> From calf foetal red blood cells; 17 beta-hydroxy-5 alpha-androstan-3-one and progesterone can act as substrates of 3 beta and 20 alpha reductase activities, respectively
Registry number: EC 1.1.1.-
Synonym: 3,20-hs oxidoreductase
(26 Jun 1999)
3 beta-hydroxy-delta 5-C(27)-steroid dehydrogenase <enzyme> Second enzyme in the sequence that converts cholesterol to bile acids; deficiency leads to chronic liver disease in childhood
Registry number: EC 1.1.1.-
Synonym: 7 alpha-hydroxycholesterol 3 beta-dehydrogenase, 7-hydroxycholesterol 3-dehydrogenase, 3 beta-hydroxy-delta(5)-c(27)-steroid oxidoreductase, 5-cholestene-3beta,7alpha-diol oxidase
(26 Jun 1999)
3 beta-hydroxysteroid oxidoreductase-delta(5) 3-ketosteroid isomerase <chemical> System found in breast cancers; consists of EC 1.1.1.145 (progesterone reductase) and EC 5.3.3.1 (steroid delta-isomerase))
Synonym: 3 ohsteroid dehydrogenase-isomerase, delta 5-3 beta hydroxysteroid dehydrogenase-isomerase, 3 beta-hydroxysteroid dehydrogenase-isomerase, 3 beta-hydroxysteroid dehydrogenase-delta(5)-delta(4)-isomerase, 3 beta-hydroxysteroid dehydrogenase-5--4-ene-isomerase, 3-beta-hydroxysteroid dehydrogenase-delta(5-4)-isomerase, 3 beta hydroxysteroid dehydrogenase-delta5-delta4-isomerasease, 3 beta-ol dehydrogenase-delta(4)-delta(5) isomerase, 3 beta-hydroxy-5-ene steroid dehydrogenase-delta 5-delta 4 isomerase
(26 Jun 1999)
3 (or 17)-beta-hydroxysteroid dehydrogenase <enzyme> Acts on both 3 beta or 17 beta hydroxysteroids; 17 beta type 1 is probably estradiol dehydrogenases; for 3 or 17 alpha-hydroxysteroids see EC 1.1.1.209; was mapped to testosterone dehydrongenases (85-93) (see under 17-hydroxysteroid dehydrogenases (85-90); on-line search 17-hydroxysteroid dehydrogenases (85-93), index medicus search testosterone dehydrogenases (91-93), 17-hydroxysteroid dehydrogenases (85-90)
Registry number: EC 1.1.1.51
Synonym: 3 beta,17 beta-hydroxysteroid dehydrogenase, 3,17-beta-hsdase, 17beta-hydroxysteroid dehydrogenase, 17beta hsd1
(26 Jun 1999)
3-oxo-5 beta-steroid delta 4-dehydrogenase <enzyme> Do not confuse with EC 1.3.1.23 (cholestenone 5 beta-reductase) which is also steroid 5 beta-reductase in chemline; do not use for enzyme using NADP-see EC 1.3.1.23 and EC 1.3.1.3
Chemical name: 3-oxo-5 beta-steroid delta(4)dehydrogenase
Registry number: EC 1.3.99.6
Synonym: steroid 5 beta-reductase, testosterone 5 beta-reductase, 4-ene-5 beta-reductase, delta(4)-3-ketosteroid-5 beta-(acceptor)-reductase, testosterone 5beta-reductase, delta(4)-5beta-reductase, cytosolic 4-ene-reductase
(26 Jun 1999)
4-androstene-3,17-dione-16 beta-hydroxylase <enzyme> Catalyses androst-4-en-3,17-dione to 16 beta-hydroxyandrost-4-en-3,17-dione; cytochrome p450 2b1 is both a androstenedione 16beta-hydroxylase and a testosterone 16beta-hydroxylase
Registry number: EC 1.14.99.-
Synonym: aedo-16-hydroxylase, steroid 16-hydroxylase, cytochrome p450 2b2, cyp 2b2, cyp2b2
(26 Jun 1999)
4-methylumbelliferyl-beta-galactosidase <enzyme> Non-specific brain enzyme; distinct from EC 3.2.1.46
Registry number: EC 3.2.1.-
Synonym: 4-mub-galactosidase
(26 Jun 1999)
4-methylumbelliferyl-beta-glucosidase <enzyme> Aspect of EC 3.2.1.21
Registry number: EC 3.2.1.-
(26 Jun 1999)
4-methylumbelliferyl-tetra-N-acetyl-beta-D-chitotetraoside hydrolase <enzyme> Not identical to human plasma lysozyme
Registry number: EC 3.2.1.-
Synonym: mu-tact hydrolase
(26 Jun 1999)
4-nitrophenyl beta-galactoside hydrolase <enzyme> From biomphalaria glabrata; does not act on galactans
Registry number: EC 3.2.1.-
Synonym: para-nitrophenyl beta-galactoside hydrolase, 4-nitrophenyl-beta-d-galactosidase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á